FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely, to therapy and cardiology, and deals with treatment of arterial hypertension. For this purpose into complex of conventional therapy additionally introduced is prostaglandin E2 in form of 0.0008% solution. Prostaglandin is introduced intravenously, starting with rate 50-100 ng/kg/min, increasing rate of introduction each 10 minutes on 20-40 ng/kg/min, bringing rate to 150-300 ng/kg/min during 40-60, minutes. Altogether there are three introductions per a course with 1-2 day intervals between them.
EFFECT: additional introduction of prostaglandin E2 in elaborated doses and regimen ensures efficient normalisation of arterial pressure during long term due to enhance of excretion of prostaglandins by kidneys, expressed vasodilation of vessels of kidneys, heart and brain, as well as normalisation of functional activity of platelets.
6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MODELING MALIGNANT ARTERIAL HYPERTENSION DISEASE | 2004 |
|
RU2266572C1 |
| METHOD FOR PROPHYLAXIS OF CARDIAC ACTIVITY RHYTHM DISORDER | 2005 |
|
RU2283099C1 |
| METHOD FOR CORRECTING POSITION OF DISPLACED VERTEBRAE CAUSING SEGMENTARY INNERVATION OF BODY ORGANS AND TISSUES | 1994 |
|
RU2085175C1 |
| METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF BRONCHIAL ASTHMA | 2008 |
|
RU2389023C2 |
| METHOD OF TREATING METABOLIC SYNDROME | 2009 |
|
RU2398562C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386134C1 |
| METHOD FOR PREDICTION OF PROGRESSION OF HEPATIC FAILURE IN INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2372619C1 |
| METHOD OF TREATING VARIX DILATATION OF ESOPHAGUS IN CASE OF PORTAL HYPERTENSION | 2010 |
|
RU2435591C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CHRONIC HEPATITIS AND CIRRHOSIS AT HEPATOCEREBRAL DYSTROPHY | 2005 |
|
RU2287165C1 |
| METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
